Bio-Connect

Anti-Human IL-2 Receptor alpha Antibody [PS01-03]

HA721281
HUABIO
ApplicationsELISA
Product group Antibodies
TargetIL2RA
100 ul
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    HUABIO
  • Product Name
    Anti-Human IL-2 Receptor alpha Antibody [PS01-03]
  • Delivery Days Customer
    2
  • Applications
    ELISA
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    PS01-03
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3559
  • Target name
    IL2RA
  • Target description
    interleukin 2 receptor subunit alpha
  • Target synonyms
    CD25, IDDM10, IL2R, IMD41, TCGFR, p55, interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2R subunit alpha, TAC antigen, interleukin 2 receptor, alpha
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP01589
  • Protein Name
    Interleukin-2 receptor subunit alpha
  • Scientific Description
    Interleukin-2 receptor alpha chain (also called CD25) is the human protein encoded by the IL2RA gene. The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolysis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is currently unknown. It is a type I transmembrane protein present on activated T cells, activated B cells, some thymocytes, myeloid precursors, and oligodendrocytes. IL2RA is expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, neuroblastomas, mastocytosis and tumor infiltrating lymphocytes. It functions as the receptor for HTLV-1 and is consequently expressed on neoplastic cells in adult T cell lymphoma/leukemia. Its soluble form, called sIL-2R may be elevated in these diseases and is occasionally used to track disease progression. Infection by the protozoan Trypanosoma cruzi causes Chagas disease, characterized by a reduction in the amount of IL2RA expressed on the surface of immune cells. This leads to chronic immune suppression, becoming increasingly severe over the course of many years and ultimately resulting in death if left untreated.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116161